The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Uses and Use Restrictions
Financial and technical resources are intended to be utilized for non-research activities that (1) strengthen epidemiologic capacity; (2) enhance laboratory capacity; (3) improve information systems; and (4) enhance collaboration among epidemiology, laboratory, and information systems components of public health departments.
Activities may include those that enable a public health organization to establish and maintain a capable and qualified workforce, achieve modern and well-equipped public health laboratories, implement up-to-date health information systems, and institute systems that foster communication and appropriate integration across epidemiology, laboratory, and health information systems.
Federal Financial Assistance (FA) and Direct Assistance (DA) are authorized.
Project funds may be used for costs associated with planning, organizing, and the implementation of other program elements to build public health epidemiology, laboratory, and health information systems capacity.
Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services (e.g., contractual support).
Funds may not be used for research or clinical care.
Generally, awardees may not use funds to purchase furniture.
Other than for normal and recognized executive-legislative relationships, no funds may be used for (1) publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body, or (2) the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body.
(See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on lobbying for CDC awardees).
Funds awarded to grantees are fully discretionary and funding levels are determined each fiscal year.
Eligible applicants consist of state, local, and U.S.
territory/possession governments currently funded under CDC-RFA-CI10-1012 or CDC-RFA-CK12-1201.
Specifically, these include: all 50 states, Washington, D.C., 5 largest local health departments (Chicago, Illinois; Houston, Texas; Los Angeles, California; New York City, New York; Philadelphia, Pennsylvania;), the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau or their bona fide agents.
Direct beneficiaries include all 50 states, Washington, D.C., 5 largest local health departments (Chicago, Illinois; Houston, Texas; Los Angeles, California; New York City, New York; Philadelphia, Pennsylvania;), the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau or their bona fide agents.
Allowable costs will be determined in accordance with OMB Circular No. A-87 for State, Local, and Indian Tribal governments. OMB Circular No. A-87 applies to this program.
Aplication and Award Process
Preapplication coordination is required.
Environmental impact information is not required for this program.
This program is eligible for coverage under E.O.
12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.
OMB Circular No. A-102 applies to this program. This program is excluded from coverage under OMB Circular No. A-110.
Applications that are complete and responsive will be evaluated for scientific and technical merit and receive support. CDC will not review incomplete and non-responsive applications. Applications that are complete and responsive will undergo an objective review process, receive a written critique and be scored according to the published review criteria. Successful applicants will receive a Notice of Award (NOA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized Grants Management Officer. Initial award provides funds for the first budget period (usually 12 months) and the NOA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any.
May 16, 2014 Deadline subject to change annually (one date will be provided in the published FOA via Grants.gov).
Public Health Service Act Sections 301(a)[42 U.S.C. 241(a)] and 317(k)(2)[42 U.S.C. 247b(k)(2)].
Range of Approval/Disapproval Time
From 90 to 120 days.
From 90 to 120 days. Renewals of funding will be determined on availability of funding and response to continuation application.
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance
Financial assistance is provided for a 12-month budget period with project period up to five years subject to availability of funds and satisfactory continuation application from the grantee. Method of awarding/releasing assistance: lump sum.
Post Assistance Requirements
Annual or semiannual progress reports are required.
Financial status reports are required no later than 30 days after the end of each budget period.
Final financial status and performance reports are required 90 days after the end of the project period.
Cash reports are not applicable.
Annual or semiannual progress reports are required.
Financial status reports are required no later than 90 days after the end of each budget period.
Performance monitoring is not applicable.
Quarterly expenditure reports required, no more than 30 days after the end of each quarter.
These reports must be submitted to the attention of the Grants Management Specialist listed in the Section VII below entitled "Agency Contacts".
No later than 10 days after the end of each calendar quarter, the recipients must submit a calendar quarter cash transaction report (SF-272 or top portion of the SF-425 Financial Report Form) to the Payment Management System (PMS).
The reporting schedule will be based on the requirements listed in the ELC funding opportunity announcements.
Description Funded applicants must provide an interim and annual progress report.
Federal Financial Reports (SF 425) and Final Progress Report are due no more than 90 days after the end of the budget period.
All reports must be submitted to the Grants Management Specialist indicated in the NoA.
Federal Financial Reports (SF 425) are due no more than 90 days after the end of the budget period.
Federal Financial Reports and Progress Reports are required, no more than 90 days after the end of the budget/project period.
No performance monitoring is required.
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133.
Financial records, supporting documents, statistical records, and all other records pertinent to the grant program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42.
(Cooperative Agreements) FY 13 $0; FY 14 est $50,655,101; and FY 15 est $50,655,101 - Funding provided under this CFDA # is one of two sources of funds for the ELC cooperative agreement (CK14-1401) and does not represent sole funding for ELC programs for FY13.
Range and Average of Financial Assistance
Subject to availability of Funds.
Regulations, Guidelines, and Literature
42 CFR 45, basic grant administration policies of DHHS and PHS are also applicable, 46 CFR 74 and 45 CFR 92, PHS Grants Policy Statement, DHHS publication No. (OASH) 94-50,000 (Rev.) April 1, 1994
Regional or Local Office
See Regional Agency Offices. Alvin Shultz Scientific and Program Services Branch
Division of Preparedness and Emerging Infections
National Center for Emerging and Zoonotic Diseases
Centers for Disease Control and Prevention
Department of Health and Human Services
1600 Clifton Road, NE, Mailstop C18, Atlanta
Phone: (404) 639-7028
Fax: (404) 639-7880
For financial, grants management, or budget assistance, contact:
Grants Management Specialist
Department of Health and Human Services
CDC Procurement and Grants Office
2920 Brandywine Road, MS K70
Atlanta, GA 30341.
Angelica O"Connor 1600 Clifton Rd, NE (MS-C18), Atlanta, Georgia 30333 Email: AMOConnor@cdc.gov Phone: 4046397379
Criteria for Selecting Proposals
Applications will be evaluated based on: (1) clearly provide a plan that includes quantitative process and outcome measures (2) provide adequate and clear information to enable the reviewer to gain a reasonable understanding of the applicant s recent and current efforts to address the issues and (3) provide a realistic plan with activities that can be achieved in year one and subsequent years. Other criteria will be listed in the individual funding opportunity announcements.
J. Gregory Dees, an internationally acclaimed Professor of the Practice of Social Entrepreneurship and co-founder of the Center for the Advancement of Social Entrepreneurship at Duke University’s Fuqua School of Business, passed away at age 63 at the Duke Hospital Friday.